AU2589399A - Human short-chain tnf-receptor family protein - Google Patents

Human short-chain tnf-receptor family protein

Info

Publication number
AU2589399A
AU2589399A AU25893/99A AU2589399A AU2589399A AU 2589399 A AU2589399 A AU 2589399A AU 25893/99 A AU25893/99 A AU 25893/99A AU 2589399 A AU2589399 A AU 2589399A AU 2589399 A AU2589399 A AU 2589399A
Authority
AU
Australia
Prior art keywords
receptor family
family protein
human short
chain tnf
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25893/99A
Other languages
English (en)
Inventor
Neil C. Corley
Preeti Lal
Y. Tom Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Publication of AU2589399A publication Critical patent/AU2589399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU25893/99A 1998-02-17 1999-02-05 Human short-chain tnf-receptor family protein Abandoned AU2589399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2480898A 1998-02-17 1998-02-17
US09024808 1998-02-17
PCT/US1999/002570 WO1999041374A2 (fr) 1998-02-17 1999-02-05 Proteine de la famille des recepteurs a chaine courte humains du tnf

Publications (1)

Publication Number Publication Date
AU2589399A true AU2589399A (en) 1999-08-30

Family

ID=21822505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25893/99A Abandoned AU2589399A (en) 1998-02-17 1999-02-05 Human short-chain tnf-receptor family protein

Country Status (5)

Country Link
EP (1) EP1054961A2 (fr)
JP (1) JP2002503464A (fr)
AU (1) AU2589399A (fr)
CA (1) CA2321105A1 (fr)
WO (1) WO1999041374A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003521242A (ja) * 1999-11-12 2003-07-15 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド １９個のヒト分泌タンパク質
EP2332956A1 (fr) * 2002-07-08 2011-06-15 Genentech, Inc. Anticorps qui se lie á PRO71238
KR101278690B1 (ko) * 2009-10-19 2013-06-24 한올바이오파마주식회사 변형된 인간 종양 괴사 인자 수용체-1 폴리펩티드 또는 그의 절편 및 그의 제조방법
BR112012013330A2 (pt) 2009-12-02 2017-03-28 Acceleron Pharma Inc composições e métodos para aumentar meia vida do soro de proteínas de fusão fc
PL2657252T3 (pl) * 2010-12-23 2017-08-31 Hanall Biopharma Co., Ltd. Modyfikowany polipeptyd ludzkiego receptora-1 czynnika martwicy nowotworu lub jego fragment i sposób ich wytwarzania
EP2718328A4 (fr) 2011-06-08 2014-12-24 Acceleron Pharma Inc Compositions et procédés pour augmenter la demi-vie sérique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
WO1997033904A1 (fr) * 1996-03-12 1997-09-18 Human Genome Sciences, Inc. Recepteurs contenant un domaine de mort cellulaire

Also Published As

Publication number Publication date
WO1999041374A3 (fr) 1999-09-23
CA2321105A1 (fr) 1999-08-19
WO1999041374A2 (fr) 1999-08-19
JP2002503464A (ja) 2002-02-05
EP1054961A2 (fr) 2000-11-29

Similar Documents

Publication Publication Date Title
AU5721798A (en) Human mage-like protein
AU2434199A (en) Protein
AU4834999A (en) Human signal peptide-containing proteins
AU4409099A (en) Human transmembrane proteins
AU6518399A (en) Human ankyrin family protein
AU4184299A (en) Human apoptosis associated proteins
AU1608201A (en) Human zven proteins
AU6142899A (en) Human transferase proteins
AU4480697A (en) Human nm23-like protein
AU4202699A (en) Human socs proteins
AU2589399A (en) Human short-chain tnf-receptor family protein
AU9017598A (en) Human frezzled-like protein
AU8665898A (en) Human longevity-assurance protein homologs
AU4483500A (en) Human membrane-associated proteins
AU5148098A (en) Human eosinophil-derived basic protein
AU4978499A (en) Human transport protein homologs
AU3983899A (en) Human promonocyte associated protein: prmnc
AU4849299A (en) Human emr1-like g protein coupled receptor
AU2227999A (en) Human ependymin
AU2593199A (en) Human smn-like protein
AU4992099A (en) Human presenilin-associated protein
AU4744997A (en) Novel human phospholemman-like protein
AU2101799A (en) Human vps35/mem3-related protein
AU2659799A (en) Human receptor proteins
AU4438599A (en) Human arf-related proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase